The PGY2 Solid Organ Transplant residency program is designed to develop competencies necessary for independent specialized practice in solid organ transplant, including proficiency in caring for a variety of heart, lung, liver, kidney and pancreas transplant recipients. The primary focus of the residency is to enhance skills related to patient care, clinical research, and teaching. Upon completion of this residency, graduates will be prepared to practice as a solid organ transplant pharmacotherapy specialist in an acute or ambulatory care environment.
Tampa General Hospital (TGH) is a 1,010 bed, private, not for profit teaching institution that ranks as one of the busiest transplant programs in the US, with over 300 kidney and kidney/pancreas transplants, 130 liver transplants, 40 heart transplants, and 40 lung transplants performed annually. Additionally, 5-10 pediatric kidney transplants are performed each year.
The PGY2 solid organ transplant resident will be an integral part of the health care team for each transplant service, providing comprehensive pharmaceutical care services including pre-transplant evaluations, initial transplant consults, pharmacokinetic analyses, drug information, intensive monitoring and discharge education to patients on service. The resident will also have the opportunity to enhance their precepting skills while serving as a primary preceptor for both rotating students and PGY-1 residents. In the ambulatory care setting, the resident will gain experience in managing a variety of chronic disease states through time spent with abdominal and cardiothoracic transplant recipients.
Residents completing this residency program will have a variety of teaching responsibilities throughout the year, including formal presentations to transplant providers and pharmacy staff as well as significant patient interactions through education and counseling. Additionally, the PGY2 solid organ transplant resident will become proficient in completing clinical research projects designed to advance transplant pharmacy knowledge and practice. The resident will complete one formal IRB approved research project and will subsequently lead the development and writeup for IRB approval for a second research project. The resident will aim to present his/her research project at one of the major annual transplant conferences (either American Transplant Congress or International Society of Heart and Lung Transplant).
Site Special Features: Tampa General Hospital has the only Level I Trauma Center in West Central Florida, as well as a regional burn center, regional digestive disorders center, joint center, neurosciences center, children's medical center, and cardiac institute. Clinical rotations will be completed at TGH and at the TGH transplant clinics. Teaching experiences in the form of didactic lectures and clinical skills labs will be conducted at various affiliated colleges of pharmacy. Fringe Benefits: Competitive salary, health insurance, sick leave, paid vacation, retirement plan contributions, professional travel reimbursement, lab coats, resident office, resident computer, and ACLS Certification.
Special Requirements for Acceptance: Licensure in the state of Florida, PharmD degree and completion of an ASHP-accredited PGY-1 residency is required.
About Tampa General Hospital
Tampa General Hospital is a 1,010-bed, academic teaching facility that is committed to providing outstanding pharmacy post-graduate residency training. The Department of Pharmacy offers four ASHP-accredited residency training programs dedicated to developing clinical practice competencies while promoting leadership, confidence, and professional skills. Each program combines clinical training with teaching and scholarly activities to develop a well-rounded clinical practitioner. While the programs have required rotations, each provides flexibility to meet the needs of the individual resident.